Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Role of Endocrine Disruptors in Thyroid Cancer

Cross-sectional Case-control Study on the Role of Endocrine Disruptors in Thyroid Cancer

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

the relationship between human exposure to EDCS and TC is poorly investigated and still unclear. The aim of this study is to evaluate the possible role of old and new generation endocrine disruptors in thyroid cancer. The primary aim is to evaluate the difference in the average levels of the main endocrine disruptors (PFAS, including: PFOA, PFOS, PFDA, PFUnA, PFHpS and possibly subsequently other categories, such as bisphenols, phthalates, parabens, PCBs, flame retardants) between patients with and without a diagnosis of thyroid cancer through highly sensitive, selective and precise mass spectrometry methods, such as liquid chromatography combined with tandem mass spectrometry (LC-MS / MS). The secondary aim is to evaluate the relationship between the concentrations of endocrine disruptors and some anamnestic variables studied (for example the type of diet, the use of personal care products).

Who May Be Eligible (Plain English)

Who May Qualify: - patients with a diagnosis of thyroid cancer in the last 5 years (arm A) - patients without a diagnosis of thyroid cancer will match patients included in arm A Who Should NOT Join This Trial: - subjects under 18 years old - patients unable to sign the willing to sign a consent form or questionnaires Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * patients with a diagnosis of thyroid cancer in the last 5 years (arm A) * patients without a diagnosis of thyroid cancer will match patients included in arm A Exclusion Criteria: * subjects under 18 years old * patients unable to sign the informed consent or questionnaires

Treatments Being Tested

DIAGNOSTIC_TEST

Blood and urine diagnostic evaluation

Blood and urine samples will be obtained from both case and control groups in order to evaluate EDCs concentrations

Locations (1)

Istituto Auxologico Italiano, IRCCS
Milan, Italy